Morgan Stanley keeps AUD 3.30 target for Sigma Healthcare stock

Morgan Stanley maintained its Buy rating on Sigma Healthcare and set an AUD 3.30 price target on October 13, 2026, according to Markets Insider. Against the ASX price of AUD 2.81 on October 15, 2026, that target is 17.44 percent higher. Sigma Healthcare stock was at EUR 1.74 at Lang & Schwarz on October 15, 2026 at 6:42 p.m. CEST, unchanged against the ASX prior close of October 14, 2026.

Annual meeting sets the next date

Sigma Healthcare's annual general meeting is scheduled for October 21, 2026. The company's official meeting notice says shareholders will consider the financial reports for the year ended June 30, 2026, director re-elections and executive incentive resolutions, including a proposed grant of 1,084,167 rights to Chief Executive Officer Vikesh Ramsunder, according to Sigma Healthcare.

Fiscal year revenue reached AUD 10.8 billion

For fiscal year 2026, Sigma Healthcare posted revenue of AUD 10.8 billion, up 81.00 percent from fiscal year 2025. Net income reached AUD 709.2 million, up 34.00 percent from the prior year, while the profit margin fell to 6.50 percent from 8.80 percent, according to Simply Wall St. The figures describe the post-merger scale of the business, but the lower margin keeps profitability central to the investment case.

Price position and valuation

The ASX share price of AUD 2.81 on October 15, 2026 stood 10.94 percent above the 52-week low of AUD 2.47 and 12.19 percent below the 52-week high of AUD 3.20. Sigma Healthcare had a market capitalization of AUD 32.4 billion, a P/E ratio of 45.62 and a dividend yield of 1.00 percent on October 15, 2026. The Morgan Stanley target of AUD 3.30 therefore sits above both the latest ASX price and the annual high.

Comparison with peers

Sigma Healthcare (ASX, AUD): 0.00 percent, P/E 45.62, market capitalization AUD 32.4 billion.

Ramsay Health Care (ASX, AUD): plus 0.42 percent, P/E 40.35, market capitalization AUD 12.6 billion.

Sonic Healthcare (ASX, AUD): plus 0.65 percent, P/E 15.03, market capitalization AUD 9.1 billion.

After-hours price stays unchanged

At Lang & Schwarz, Sigma Healthcare stood at EUR 1.74 on October 15, 2026 at 6:42 p.m. CEST. The Australian listing was unchanged against the ASX prior close of October 14, 2026, while the company moves toward its October 21 annual meeting.

The further course of trading is shown by the continuously updated real-time quote of Sigma Healthcare stock.

Market context: Market report S&P/ASX 200.

More news and analyses on Sigma Healthcare stock